The Food and Drug Administration has announced a public workshop entitled, “Scientific Evidence in the Development of Human Cells, Tissues, and Cellular and Tissue-Based Products Subject to Premarket Approval.” [Read more…]
Understand Stem Cell Market Needs, so You Can Precisely Meet Them – with Minimal Time, Cost, and Risk
As a provider of stem cell products and technologies, you know you need to:
- Make effective product development decisions
- Sell more effectively
- Generate improved revenues
- Take market share
Without strategic guidance on which to base your actions, you’re in a difficult position. New products that don’t sell well are costly mistakes. On the other hand, repeatedly launching high-demand products and skillfully addressing the unmet needs of your clients is certain to position you as a market leader.
[Read more…]
Will You Be Attending? FDA Reschedules Part 15 Public Hearing for September 12-13 (5 Month Delay)
Recently, we explored the overwhelming response received by the FDA for participation in its Part 15 Hearing intended to review “Draft Guidances Relating to the Regulation of Human Cells, Tissues or Cellular or Tissue-Based Products.”
With approximately 600 registrations and 100 people interested in presenting, it was clear that individuals across country are concerned about these draft guidances that appear to be a further restriction on stem cell therapy within the U.S.
As a result of this massive registration response, the FDA cancelled the original April 13, 2016, hearing date and announced that it would be rescheduled for an undetermined date. [Read more…]
Adult Stem Cell Therapies and the First Inter-American Stem Cell Conference
I am honored to release this interview with Ricardo de Cubas, Founder, President, and CEO of Regenestem, LLC. Regenestem is a medical practice company focused on adult stem cell therapies and physician training with particular growth in Latin America.
Regenestem is also presenting an upcoming conference in Cuba devoted to regenerative medicine, in association with the Cuban Institute of Hematology and Immunology. The First Inter American Stem Cell Conference will be held over October 13-15, at the Palacio de Convenciones, in Havana, to explore whether stem cell therapies are ready to become a standard form of treatment. It will also provide hands-on training workshops.
To learn more about progress with adult stem cell therapies and opportunities for education and collaboration in this area, enjoy the interview with Ricardo de Cubas below. [Read more…]
Major Week for Stem Cells – Acquisitions, Investments, License Agreements, and More
We’ve released new content on stem cell markets that we are excited to share with you. Let me know what you think?
CellPlan Launches The World’s First Global Stem Cell Healthcare Plan
CellPlan today announced the creation of the world’s first global stem cell healthcare plan, which will be launched at the World Cord Blood Congress Europe 2016 in London this month. The UK company said that the new medical insurance product could revolutionize stem cell healthcare by making stem cell transplants affordable for families who require treatment for life threatening diseases. [Read more…]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 10
- Next Page »